Walleye Capital
ALNY icon

Walleye Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History

Walleye Capital’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$950K Buy
3,155
+516
+20% +$156K ﹤0.01% 2173
2026
Q1 		$873K Sell
2,639
-3,329
-56% -$1.13M ﹤0.01% 2201
2025
Q4 		$2.37M Sell
5,968
-16,377
-73% -$7.25M 0.01% 1743
2025
Q3 		$10.2M Sell
22,345
-16,370
-42% -$6.67M 0.04% 541
2025
Q2 		$12.6M Buy
38,715
+36,345
+1,534% +$10.1M 0.05% 406
2025
Q1 		$640K Sell
2,370
-17,746
-88% -$4.56M ﹤0.01% 2350
2024
Q4 		$4.73M Buy
20,116
+16,467
+451% +$4.33M 0.01% 1112
2024
Q3 		$1M Sell
3,649
-66,658
-95% -$17.4M ﹤0.01% 2644
2024
Q2 		$17.1M Buy
70,307
+23,449
+50% +$3.7M 0.03% 433
2024
Q1 		$7M Buy
46,858
+22,044
+89% +$3.68M 0.01% 1067
2023
Q4 		$4.75M Buy
+24,814
New +$4.23M 0.01% 1141
2023
Q3 		– Sell
-1,040
Closed -$198K – 4827
2023
Q2 		$198K Buy
+1,040
New +$206K ﹤0.01% 3091
2022
Q1 		– Sell
-3,772
Closed -$640K – 2262
2021
Q4 		$640K Buy
3,772
+104
+3% +$19.3K 0.02% 841
2021
Q3 		$693K Buy
+3,668
New +$688K 0.02% 634
2020
Q1 		– Sell
-1,870
Closed -$215K – 872
2019
Q4 		$215K Buy
+1,870
New +$186K 0.01% 1075
2018
Q3 		$751K Buy
+8,585
New +$864K 0.35% 81

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Walleye Capital's ALNY Position: Q2 2026 in Review

Walleye Capital increased its Alnylam Pharmaceuticals (ALNY) stake by 20% in Q2 2026, buying an estimated $156K and bringing the position to 3,155 shares worth $950K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Walleye Capital first reported a position in ALNY in Q3 2018 and has held it in 16 quarters since. The position peaked at $17.1M in Q2 2024. 791 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Walleye Capital held 3,155 shares of Alnylam Pharmaceuticals worth $950K as of Q2 2026.
  • Walleye Capital bought 516 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $156K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #2173 holding.
  • Walleye Capital first reported a position in Alnylam Pharmaceuticals in Q3 2018 and has held it in 16 quarters since.
  • Walleye Capital's Alnylam Pharmaceuticals position peaked at $17.1M in Q2 2024.
  • 791 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.